WCMC logo
PMKB
  • WCMC logoPMKB
  • Genes
  • Variants
  • Interpretations
  • Tumor Types
  • Primary Sites
  • Activity
  • Login
SMAD4
  • Information
  • View History
  • Pending Review
SMAD4 D351G
GeneSMAD4
Variantmissense
Amino Acid ChangeD351G
Transcript ID (GRCh37/hg19)ENST00000342988
Codon351
Exon9
Germline/Somatic?Somatic
Pertinent Negative In
Tumor TypePrimary Site
See All Pertinent Negatives

Interpretations

Sort by
Page
Show

Tier 2
SMAD4
Variants
SMAD4 D351G
Primary Sites
Pancreas
Tumor Types
Adenocarcinoma
Interpretation

SMAD4 encodes a tumor suppressor and transcription factor that is a downstream effector in the TGF-ss signal transduction pathway. Germline mutations in SMAD4 have been associated with juvenile polyposis syndrome. SMAD4 is mutated in one third of colorectal cancer and half of pancreatic tumors. Genetic alterations in SMAD4 have been identified in 33% of pancreatic adenocarcinomas. SMAD4 inactivation by allelic deletion or mutation mainly occurs in late stage pancreatic ductal adenocarcinoma and is associated with poorer prognosis. SMAD4 D351G lies at a hotspot residue within the MH2 domain of the Smad4 protein (UniProt.org). D351G has been identified in sequencing studies, but has not been biochemically characterized and therefore, its effect on Smad4 protein function is unknown. The SMAD4 D351H variant has been described in human colorectal cancer cell lines and reported as likely oncogenic, suggesting that the D351G variant is also likely to be oncogenic. SMAD4 loss has been found to increase resistance to the chemotherapeutic agent 5'-fluorouracil.

Last updated: 2019-01-22 18:39:52 UTC
Read More
PMKB Bot
  • Genes
  • Variants
  • Interpretations
  • Tumor Types
  • Primary Sites
  • Activity

Disclaimer: You assume full responsibility for all risks associated with using this PMKB website. The Englander Institute for Precision Medicine at Weill Cornell Medicine makes no guarantee of the comprehensiveness, reliability or accuracy of the information on this website and assumes no responsibility for errors in the information associated with this web site. Healthcare providers and patients must integrate all clinical and laboratory findings as well as information from a variety of sources before deciding on appropriate clinical care options.


When using PMKB, please cite: Huang et al., JAMIA 2017


HELP
User Guide
Video Tutorial
INFO
About
Latest
API
Twitter
CONTACT US
Contact

Englander Institute for Precision Medicine
© Weill Cornell Medicine | Version 1.7.2Privacy PolicyTerms of use